Trial · NCT01742286
Adverse events1,976
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,976
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Fasted Ceritinib 300mg/m2 | 1 | 5 | |
| other | Anaemia | Blood and lymphatic system disorders | Fasted Ceritinib 450mg/m2 | 3 | 12 | |
| other | Anaemia | Blood and lymphatic system disorders | Fasted Ceritinib 510mg/m2 | 3 | 13 | |
| other | Anaemia | Blood and lymphatic system disorders | Fasted Ceritinib 560mg/m2 | 1 | 2 | |
| other | Anaemia | Blood and lymphatic system disorders | Fed Ceritinib 320mg/m2 | 3 | 4 | |
| other | Anaemia | Blood and lymphatic system disorders | Fed Ceritinib 400mg/m2 | 0 | 5 | |
| other | Anaemia | Blood and lymphatic system disorders | Fed Ceritinib 500mg/m2 | 11 | 42 | |
| other | Anaemia | Blood and lymphatic system disorders | Fasted+Fed All Patients | 22 | 83 | |
| other | Bone marrow disorder | Blood and lymphatic system disorders | Fasted Ceritinib 300mg/m2 | 0 | 5 | |
| other | Bone marrow disorder | Blood and lymphatic system disorders | Fasted Ceritinib 450mg/m2 | 0 | 12 | |
| other | Bone marrow disorder | Blood and lymphatic system disorders | Fasted Ceritinib 510mg/m2 | 1 | 13 | |
| other | Bone marrow disorder | Blood and lymphatic system disorders | Fasted Ceritinib 560mg/m2 | 0 | 2 | |
| other | Bone marrow disorder | Blood and lymphatic system disorders | Fed Ceritinib 320mg/m2 | 0 | 4 | |
| other | Bone marrow disorder | Blood and lymphatic system disorders | Fed Ceritinib 400mg/m2 | 0 | 5 | |
| other | Bone marrow disorder | Blood and lymphatic system disorders | Fed Ceritinib 500mg/m2 | 0 | 42 | |
| other | Bone marrow disorder | Blood and lymphatic system disorders | Fasted+Fed All Patients | 1 | 83 | |
| other | Leukocytosis | Blood and lymphatic system disorders | Fasted Ceritinib 300mg/m2 | 0 | 5 | |
| other | Leukocytosis | Blood and lymphatic system disorders | Fasted Ceritinib 450mg/m2 | 0 | 12 | |
| other | Leukocytosis | Blood and lymphatic system disorders | Fasted Ceritinib 510mg/m2 | 1 | 13 | |
| other | Leukocytosis | Blood and lymphatic system disorders | Fasted Ceritinib 560mg/m2 | 0 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01742286/events